Drug Database
Back to search

Poland· PL-100515267

Lyvdelzi

A other drugs for bile therapy product containing seladelparum, registered in Poland by Gilead Sciences Ireland UC. The same ATC class is registered in 4 of our 19 countries.

ATC A05AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLyvdelziATCA05AXREGISTER NO.PL-100515267PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about seladelparumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Seladelparum is registered in 4 of 19 countries.

Countries holding a registration under ATC A05AX (other drugs for bile therapy), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search seladelparum products by name

Seladelparum · ATC A05AX

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Seladelparum
Manufacturer
Gilead Sciences Ireland UC
Country
Poland (PL)
ATC code
A05AX
ATC class
Other drugs for bile therapy
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05391507148452
  • gtin
    04150196244477
  • gtin
    04150197439919

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Seladelparum in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All seladelparum products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Lyvdelzi
  • Liechtenstein · Lyvdelzi
  • Norway · Lyvdelzi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f16f3699-aadb-4eec-b1b7-1ce2f34f0738
GET /v1/drugs/f16f3699-aadb-4eec-b1b7-1ce2f34f0738?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05391507148452 ¦ Rp ¦ EU/1/24/1898/001 ¦ 161032\n30 kaps. \n¦ UR/Z/4b/110/25 - 04150196244477 ¦ UR/Z/4b/119/25 - 04150196244477 ¦ UR/Z/4b/195/25 - 04150197439919 ¦ UR/Z/4b/293/25 - 04150197439919 ¦ UR/Z/4b/033/26 - 04150197439919",
  "substance": "Seladelparum 10 mg",
  "common_name": "Seladelparum",
  "pl_product_id": "100515267",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about seladelparum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console